TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 89 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2014. The put-call ratio across all filers is 8.57 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $513 | -0.2% | 13,557 | 0.0% | 0.03% | -8.6% |
| Q2 2023 | $514 | +56.2% | 13,557 | 0.0% | 0.04% | +40.0% |
| Q1 2023 | $329 | -36.7% | 13,557 | -23.2% | 0.02% | -44.4% |
| Q4 2022 | $520 | -99.9% | 17,657 | 0.0% | 0.04% | -8.2% |
| Q3 2022 | $507,000 | -20.5% | 17,657 | 0.0% | 0.05% | -19.7% |
| Q2 2022 | $638,000 | -16.5% | 17,657 | 0.0% | 0.06% | -10.3% |
| Q1 2022 | $764,000 | -32.8% | 17,657 | -22.4% | 0.07% | -37.0% |
| Q4 2021 | $1,137,000 | -21.4% | 22,755 | 0.0% | 0.11% | -39.3% |
| Q3 2021 | $1,447,000 | -11.6% | 22,755 | 0.0% | 0.18% | -9.2% |
| Q2 2021 | $1,637,000 | -2.4% | 22,755 | 0.0% | 0.20% | -12.9% |
| Q1 2021 | $1,678,000 | +0.4% | 22,755 | 0.0% | 0.22% | -19.6% |
| Q4 2020 | $1,671,000 | +33.9% | 22,755 | 0.0% | 0.28% | +9.8% |
| Q3 2020 | $1,248,000 | -17.5% | 22,755 | 0.0% | 0.26% | -27.4% |
| Q2 2020 | $1,513,000 | +8.6% | 22,755 | 0.0% | 0.35% | -21.5% |
| Q1 2020 | $1,393,000 | -44.3% | 22,755 | -20.0% | 0.45% | -34.2% |
| Q4 2019 | $2,500,000 | +16.7% | 28,438 | 0.0% | 0.68% | +6.9% |
| Q3 2019 | $2,143,000 | -11.8% | 28,438 | 0.0% | 0.64% | -12.4% |
| Q2 2019 | $2,429,000 | -21.0% | 28,438 | 0.0% | 0.72% | -23.4% |
| Q1 2019 | $3,074,000 | +27.7% | 28,438 | 0.0% | 0.95% | +146.6% |
| Q4 2018 | $2,407,000 | -21.9% | 28,438 | -9.5% | 0.38% | -22.0% |
| Q3 2018 | $3,081,000 | -15.0% | 31,438 | 0.0% | 0.49% | -55.6% |
| Q2 2018 | $3,623,000 | +16.7% | 31,438 | 0.0% | 1.11% | +13.2% |
| Q1 2018 | $3,104,000 | -5.7% | 31,438 | 0.0% | 0.98% | -2.7% |
| Q4 2017 | $3,292,000 | -6.4% | 31,438 | 0.0% | 1.01% | -12.9% |
| Q3 2017 | $3,518,000 | -0.1% | 31,438 | 0.0% | 1.16% | -7.9% |
| Q2 2017 | $3,523,000 | -4.5% | 31,438 | 0.0% | 1.25% | -12.9% |
| Q1 2017 | $3,689,000 | +11.5% | 31,438 | 0.0% | 1.44% | -0.4% |
| Q4 2016 | $3,309,000 | -4.7% | 31,438 | 0.0% | 1.45% | -1.7% |
| Q3 2016 | $3,474,000 | -24.1% | 31,438 | 0.0% | 1.47% | -24.0% |
| Q2 2016 | $4,577,000 | +1.6% | 31,438 | -0.1% | 1.94% | -0.3% |
| Q1 2016 | $4,507,000 | -11.5% | 31,463 | -4.6% | 1.94% | -8.7% |
| Q4 2015 | $5,095,000 | +8.2% | 32,963 | 0.0% | 2.13% | +7.0% |
| Q3 2015 | $4,710,000 | -0.9% | 32,963 | -0.3% | 1.99% | +7.4% |
| Q2 2015 | $4,753,000 | -11.1% | 33,078 | -8.3% | 1.85% | -10.0% |
| Q4 2014 | $5,346,000 | – | 36,078 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |